{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:49:40Z","timestamp":1776055780994,"version":"3.50.1"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021\u201001418"],"award-info":[{"award-number":["2021\u201001418"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023\u201002639"],"award-info":[{"award-number":["2023\u201002639"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ann Clin Transl Neurol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a nationwide, matched, register\u2010based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection. We included individuals with MS, identified via the Swedish MS register or \u2265\u20093 MS diagnoses in the National Patient Register, who initiated treatment with modafinil, amantadine, or central stimulants for ADHD (ADHD\u2010Drugs), along with untreated individuals matched on modafinil start date, age, sex, time since MS diagnosis, and prior\u2010year work loss. The main outcome was monthly work loss, defined as the sum of net days on sick leave, disability pension, and activity compensation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 2162 new modafinil users, 462 amantadine, 424 ADHD drugs, and 9762 untreated. All cohorts showed increasing work loss before index, followed by no change in work loss over the subsequent 24\u2009months. Modafinil users had a significantly greater attenuation, but with low effect size, of the increasing trajectory of average monthly work loss than untreated (\u22120.17\u2009days; 95% CI: \u22120.22, \u22120.12), with no significant differences between modafinil and other treated groups. Modafinil was the most prescribed treatment, with 1\u2010year prevalence of 8.5% in 2006 and 7% in 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>A potential minor treatment benefit is suggested by the statistically significant, small attenuation of worsening work loss following fatigue treatment initiation compared with untreated people with MS. No differences in treatment benefit were observed across fatigue treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/acn3.70259","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:02:21Z","timestamp":1763629341000},"page":"736-746","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss"],"prefix":"10.1002","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1042-4400","authenticated-orcid":false,"given":"Simon","family":"Englund","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet  Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Reutfors","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Karolinska Institutet  Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-9626","authenticated-orcid":false,"given":"Thomas","family":"Frisell","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Karolinska Institutet  Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet  Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"1","key":"e_1_2_11_2_1","article-title":"High Prevalence of Fatigue in Contemporary Patients With Multiple Sclerosis","volume":"7","author":"Broch L.","year":"2021","journal-title":"Multiple Sclerosis Journal"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02396-1"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211069070"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516667567"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5441-7"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102077"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513488234"},{"key":"e_1_2_11_9_1","unstructured":"National Institute for Health and Care Excellence \u201cMultiple Sclerosis in Adults: Management \u201d(2022) London National Institute for Health and Care Excellence (UK)."},{"key":"e_1_2_11_10_1","unstructured":"Socialstyrelsen \u201cNationella riktlinjer f\u00f6r v\u00e5rd vid multipel skleros och Parkinsons sjukdom \u2013 Prioriteringsst\u00f6d till beslutsfattare och chefer 2022. Artikelnummer 2022\u201011\u20108202. Stockholm: Socialstyrelsen \u201d (2022) https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint\u2010dokument\/artikelkatalog\/nationella\u2010riktlinjer\/2022\u201011\u20108202.pdf."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/798285"},{"issue":"1","key":"e_1_2_11_12_1","article-title":"Amantadine for Fatigue in Multiple Sclerosis","volume":"2007","author":"Pucci E.","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081802"},{"issue":"7","key":"e_1_2_11_14_1","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3623","article-title":"The Use of Modafinil for the Treatment of Fatigue in Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis of Controlled Clinical Trials","volume":"14","author":"Ghazanfar S.","year":"2024","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511402410"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100026603"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.11.1956"},{"issue":"1","key":"e_1_2_11_18_1","article-title":"Placebo Interventions for All Clinical Conditions","volume":"2010","author":"Hr\u00f3bjartsson A.","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4642"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1349"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106352"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106618"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12425"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9350-y"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1294"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0117-y"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00511-8"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13514"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517690821"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.5.962"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13532"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-016-0411-8"},{"key":"e_1_2_11_36_1","unstructured":"The Swedish Medical Products Agency \u201cL\u00e4kemedelsverkets F\u00f6reskrifter (HSLF\u2010FS 2017:74) om Begr\u00e4nsningar av F\u00f6rordnande Och Utl\u00e4mnande av Vissa L\u00e4kemedel \u201d(2017) https:\/\/www.lakemedelsverket.se\/sv\/lagar\u2010och\u2010regler\/foreskrifter\/2017\u201074#hslffs201774grundfreskrift."},{"key":"e_1_2_11_37_1","unstructured":"The European Medicines Agency \u201cModafinil\u2014Referral \u201d(2011) https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/modafinil."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2807"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104481"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.01.002"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520420096030"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100047107"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0765-6"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2005.10.008"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000232927"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.2.179"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000158272.27070.6A"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30354-9"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.09.029"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30415-4"}],"container-title":["Annals of Clinical and Translational Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.70259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acn3.70259","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.70259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:16:32Z","timestamp":1776053792000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.70259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/acn3.70259"],"URL":"https:\/\/doi.org\/10.1002\/acn3.70259","archive":["Portico"],"relation":{},"ISSN":["2328-9503","2328-9503"],"issn-type":[{"value":"2328-9503","type":"print"},{"value":"2328-9503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"2025-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}